Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
43
TLSI Quote, Financials, Valuation and Earnings
Last price:
$7.06
Seasonality move
:
29.79%
Day range:
$6.99 - $7.28
52-week range:
$3.42 - $7.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.80x
P/B ratio:
--
Volume:
32.7K
Avg. volume:
211.2K
1-year change:
48.63%
Market cap:
$352.7M
Revenue:
$29.4M
EPS (TTM):
-$2.02
Earnings Data
Next earnings date for TLSI
Mar 26
2026
Most recent earnings per share
-$0.96
Missed by $0.79
(Nov 13/2025)
Consensus Estimate
-$0.17
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TLSI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 | $12.8M | -- | -- | -$0.13 | -- |
| 11/13/2025 | Q3 | $11.8M | $11.6M | -$0.96 | -$0.17 | -$0.79 |
| 08/12/2025 | Q2 | $10.7M | $11.2M | -$0.27 | -$0.22 | -$0.05 |
| 05/15/2025 | Q1 | $9M | $9.2M | -$0.39 | -$0.20 | -$0.19 |
| 03/27/2025 | Q4 | $8.2M | $8.3M | -$0.40 | -$0.35 | -$0.05 |
| 11/14/2024 | Q3 | $7.4M | $7.3M | -$0.12 | -$0.37 | $0.24 |
| 08/15/2024 | Q2 | $6.9M | $7.4M | -$0.21 | -- | -- |
| 05/15/2024 | Q1 | $6.2M | $6.5M | -$0.60 | -$0.72 | $0.12 |
| 02/29/2024 | Q4 | $5.5M | $5.7M | -$1.57 | -$0.69 | -$0.88 |
| 11/14/2023 | Q3 | -- | $5.2M | -$0.14 | -- | -- |
| 06/30/2023 | Q2 | -- | $4.6M | -$0.61 | -- | -- |
| 03/31/2023 | Q1 | -- | $3M | -$0.57 | -- | -- |
| 12/31/2022 | Q4 | -- | $3.2M | -$75.01 | -- | -- |
| 09/30/2022 | Q3 | -- | $3.9M | -$25.95 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | $0.08 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | $0.09 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $0.09 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $0.06 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.01 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -- | -- | -- |
TriSalus Life Sciences, Inc. Earnings Questions
-
How Much did TriSalus Life Sciences, Inc. Generate in Revenue Last Quarter?
TriSalus Life Sciences, Inc. reported $11.6M worth of top line sales in its most recent quarter.
-
Did TriSalus Life Sciences, Inc. Beat Earnings Last Quarter?
TriSalus Life Sciences, Inc. announced earnings per share of -$0.96 which represents a miss of analyst forecast a -$0.17 per share.
-
Is TriSalus Life Sciences, Inc. Profitable?
TriSalus Life Sciences, Inc. reported $9.7M that represents $0.22 per share over the last quarter.
-
What is the Analyst Consensus for TriSalus Life Sciences, Inc. EPS Next Year?
TriSalus Life Sciences, Inc.'s earnings are forecast to decrease from -$1.31 per share to -$1.27 per share next year representing a decrease of -39.78%.
-
When is TriSalus Life Sciences, Inc.'s Earnings Date?
TriSalus Life Sciences, Inc.'s next earnings date is March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
